This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research, Université De Lille. Active years: 2026.
Company Filing History:
1 out of 65 
1 out of 1,853 
1 out of 65 
Years Active: 2026
Title: The Innovative Contributions of Valentin Guillaume
Introduction
Valentin Guillaume is a notable inventor based in Faches-Thumesnil, France. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that serve as inhibitors of endoplasmic reticulum aminopeptidases (ERAP). His work has implications for the treatment of various disorders, showcasing the potential of his inventions in medical applications.
Latest Patents
Valentin Guillaume holds 1 patent related to ERAP inhibitors. The patent discloses novel compounds of formula (I) that are useful as inhibitors of ERAP, specifically targeting ERAP2. These compounds are particularly relevant for therapeutic use in the treatment or prophylaxis of proliferative disorders, autoinflammatory disorders, and autoimmune disorders.
Career Highlights
Throughout his career, Valentin has been associated with prestigious institutions such as Université de Lille and Institut Pasteur de Lille. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Valentin has collaborated with notable colleagues, including Damien Bosc and Benoit Deprez. These partnerships have likely enriched his research and expanded the impact of his inventions.
Conclusion
Valentin Guillaume's innovative work in developing ERAP inhibitors highlights his contributions to medical science. His patents and collaborations reflect a commitment to advancing therapeutic options for various disorders.